a public good project by the
Synthesis
Company
of California

© 2026

Kathleen Dungan | doi.page

0 works0 citations0 h-index

Kathleen Dungan

The Ohio State University Wexner Medical Center(US)

Publications by Year

Research Areas

Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes and associated disorders

Most-Cited Works

→ Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes(2019)1,826 cited
→ Stress hyperglycaemia(2009)1,382 cited
→ Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial(2021)602 cited
→ Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial(2014)481 cited
→ Glucose variability and mortality in patients with sepsis*(2008)431 cited
→ Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management(2007)291 cited

→ A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings(2022)

262 cited

→ 1,5-Anhydroglucitol and Postprandial Hyperglycemia as Measured by Continuous Glucose Monitoring System in Moderately Controlled Patients With Diabetes(2006)240 cited

→ Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes(2009)212 cited

→ 1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions(2007)210 cited